Synedgen Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Synedgen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013455
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of cystic fibrosis (CF) lung infection; pulmonary infection; COPD; CF obstruction; GI infection, inflammation, mucosal damage and radiation syndrome. It also provides wound care products. The company utilizes glycomics technology platform to discover and develop ultra-purified polysaccharide molecules for therapeutic use. Synedgen is headquartered in Claremont, California, the US.

Synedgen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synedgen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Synedgen Inc, Medical Devices Deals, 2011 to YTD 2017 9
Synedgen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Synedgen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Synedgen Raises USD3.5 Million in Venture Financing 11
Synedgen Raises USD0.6 Million in Venture Financing 12
Synedgen Raises US$3.2 Million In Venture Financing 13
Partnerships 14
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 14
Licensing Agreements 15
Synspira Enters into Licensing Agreement with Synedgen 15
Synedgen Enters Into Licensing Agreement With Europharma Concepts For Oral Care Products 16
Synedgen Inc – Key Competitors 17
Synedgen Inc – Key Employees 18
Synedgen Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Synedgen Inc, Pharmaceuticals & Healthcare, Key Facts 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synedgen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synedgen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Synedgen Inc, Medical Devices Deals, 2011 to YTD 2017 9
Synedgen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Synedgen Raises USD3.5 Million in Venture Financing 11
Synedgen Raises USD0.6 Million in Venture Financing 12
Synedgen Raises US$3.2 Million In Venture Financing 13
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 14
Synspira Enters into Licensing Agreement with Synedgen 15
Synedgen Enters Into Licensing Agreement With Europharma Concepts For Oral Care Products 16
Synedgen Inc, Key Competitors 17
Synedgen Inc, Key Employees 18

★海外企業調査レポート[Synedgen Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alliant Energy Corporation:企業の戦略・SWOT・財務分析
    Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nu Skin Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Nu Skin Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nu Skin Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Fluidic Analytics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Fluidic Analytics Ltd (Fluidic Analytics) is a biotechnology company that offers diagnostic tools to sequence and characterize proteins in laboratory, medical and consumer applications. The company offers Flow Mk-1 and Flow Mk-2 products. Flow Mk-1 is a lab instrument, which comprises dispos …
  • Magnitogorsk Metallurgicheskiy Kombinat:企業の戦略・SWOT・財務情報
    Magnitogorsk Metallurgicheskiy Kombinat - Strategy, SWOT and Corporate Finance Report Summary Magnitogorsk Metallurgicheskiy Kombinat - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Swift Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • LG Uplus Corp:企業の戦略・SWOT・財務情報
    LG Uplus Corp - Strategy, SWOT and Corporate Finance Report Summary LG Uplus Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Oki Electric Industry Co., Ltd.:企業の戦略・SWOT・財務分析
    Oki Electric Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oki Electric Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Samsung Electro-Mechanics Co Ltd (009150):企業の財務・戦略的SWOT分析
    Samsung Electro-Mechanics Co Ltd (009150) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • IndiPharm Inc-製薬・医療分野:企業M&A・提携分析
    Summary IndiPharm Inc (IndiPharm) is a clinical research organization that provides drug safety services to support clinical research and marketed products. The organization offers CRO services such as preparing and filing regulatory submissions, obtaining required import and export licenses, protoc …
  • AnaptysBio Inc (ANAB):企業の財務・戦略的SWOT分析
    AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Canadian Tire Corp Ltd (CTC.A):企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Wolfgang Puck Worldwide Inc:企業の戦略・SWOT・財務分析
    Wolfgang Puck Worldwide Inc - Strategy, SWOT and Corporate Finance Report Summary Wolfgang Puck Worldwide Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • William Demant Holding AS (WDH)-医療機器分野:企業M&A・提携分析
    Summary William Demant Holding A/S (WDH) develops, manufactures and distributes products and equipment designed to aid people with hearing loss in their individual communication. Its major areas of focus include hearing devices, hearing implants, diagnostic instruments and personal communication dev …
  • Leonardo SpA (LDO):企業の財務・戦略的SWOT分析
    Leonardo SpA (LDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • eircom Holdings (Ireland) Ltd:企業の戦略・SWOT・財務情報
    eircom Holdings (Ireland) Ltd - Strategy, SWOT and Corporate Finance Report Summary eircom Holdings (Ireland) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cyteir Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cyteir Therapeutics Inc (Cyteir Therapeutics) discovers, develops and commercializes synthetic lethal therapeutics for the treatment of cancer and autoimmune disease. It specializes in the development of small molecules that targets RAD51 to induce synthetic lethality in diseases with a gain …
  • Acerinox Group:企業の戦略・SWOT・財務情報
    Acerinox Group - Strategy, SWOT and Corporate Finance Report Summary Acerinox Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tata Power Solar Systems Ltd:企業の戦略的SWOT分析
    Tata Power Solar Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • AVX Corp (AVX):企業の財務・戦略的SWOT分析
    AVX Corp (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Hasbro Inc (HAS):企業の財務・戦略的SWOT分析
    Hasbro Inc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆